PPIs labelled as ‘do not do’ in young and old

Proton pump inhibitors (PPIs) have their place but not without caution in the very young or the elderly, according to new recommendations on low value practice. The Internal Medicine Society of Australia and New Zealand (IMSANZ) recommended medication reviews in over 65-year-olds on multiple medications across a wide range of agents. President of the IMSANZ ...

Already a member?

Login to keep reading.

© 2021 the limbic